Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease.
Bangma, Amber
Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease. [electronic resource] - Alimentary pharmacology & therapeutics 06 2020 - 1105-1115 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2036
10.1111/apt.15762 doi
Adolescent
Adult
Aged
Biomarkers, Pharmacological--analysis
Case-Control Studies
Female
Genotype
Humans
Immunosuppressive Agents--therapeutic use
Inflammatory Bowel Diseases--diagnosis
Male
Middle Aged
Pharmacogenomic Testing--methods
Pharmacogenomic Variants--genetics
Predictive Value of Tests
Prognosis
Reproducibility of Results
Retrospective Studies
Transcriptome--drug effects
Treatment Outcome
Young Adult
Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease. [electronic resource] - Alimentary pharmacology & therapeutics 06 2020 - 1105-1115 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2036
10.1111/apt.15762 doi
Adolescent
Adult
Aged
Biomarkers, Pharmacological--analysis
Case-Control Studies
Female
Genotype
Humans
Immunosuppressive Agents--therapeutic use
Inflammatory Bowel Diseases--diagnosis
Male
Middle Aged
Pharmacogenomic Testing--methods
Pharmacogenomic Variants--genetics
Predictive Value of Tests
Prognosis
Reproducibility of Results
Retrospective Studies
Transcriptome--drug effects
Treatment Outcome
Young Adult